BUSINESS

• Kowa’s Glaucoma Med Glanatec Approved in Singapore
  March 12, 2020

• Drug Makers Calling Off Welcoming Ceremonies for New Hires over Coronavirus
  March 11, 2020

• Relugolix Combo Tablet Filed in EU for Uterine Fibroids
  March 11, 2020

• Janssen Files for Darzalex in Japan for Combo Therapy with Carfilzomib, Dexamethasone
  March 11, 2020

• Medipal Forms Capital and Business Alliance with Cardiac Regenerative Medicine Startup
  March 11, 2020

• Pfizer Most Affected by G1 Rule, 8 Off-Patent APIs Go into This Category: Jiho Survey
  March 10, 2020

• Japan’s 2020 Price Revision Hits Major Drugs with Double-Digit Slashes: Top 5 Product Survey
  March 10, 2020

• Takeda Continued Takecab Push for Hospital Doctors in January: Impact Track
  March 10, 2020

• Biogen’s Coronavirus Woes Grow, Japan Unit Says Its Staffers Attended Boston Confab Too
  March 10, 2020

• Shionogi Confirms Novel Coronavirus Infection at Its Group Company
  March 10, 2020

• Aducanumab “on Track” for FDA Filing: Eisai CEO
  March 9, 2020

• FTC Hits Torii with Cease, Desist, and Surcharge Payment Order over Price-Fixing for Calvan
  March 9, 2020

• Japan’s Big 3 Generic Makers See 12.2% Price Cut vs. FY2018: Jiho Poll
  March 9, 2020

• FDA Accepts Vibegron for Review; Target Date Set for Dec. 26
  March 9, 2020

• Shionogi Boosts Stake in Tetra under Alzheimer's Deal; Buyout on the Cards
  March 9, 2020

• Japan Ethical Drug Sales Down 1.2% in January: Crecon
  March 9, 2020

• Large-Scale Clinical Data Confirms Efficacy and Safety of Switch to Vemlidy for Hep B: Gilead
  March 9, 2020

• AnGes, Osaka Univ. to Pair Up to Develop DNA Vaccines for COVID-19
  March 6, 2020

• Chugai, Teijin Suffer Hefty 9% Cuts in 2020 Drug Price Revision: Jiho Poll
  March 6, 2020

• Keytruda Remains Top-Seller in February Drug Ranking: Encise
  March 6, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 298
• 299
• 300
• 301
• 302
• 303
• 304
• 305
• 306
• …
• Next ›
• 最終 »